about
Pediatric Acute Respiratory Distress Syndrome: Fibrosis versus RepairEmodin ameliorates LPS-induced acute lung injury, involving the inactivation of NF-κB in mice.Electroporation-mediated gene delivery of Na+,K+ -ATPase, and ENaC subunits to the lung attenuates acute respiratory distress syndrome in a two-hit porcine model.Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice.Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk.Electroporation-mediated in vivo gene delivery of the Na+/K+-ATPase pump reduced lung injury in a mouse model of lung contusionElectroporation-mediated delivery of genes in rodent models of lung contusion.Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.Electroporation-mediated delivery of the FER gene in the resolution of trauma-related fatal pneumonia.Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.Biological therapies in the acute respiratory distress syndrome.18F-fluoro-2-deoxyglucose PET informs neutrophil accumulation and activation in lipopolysaccharide-induced acute lung injury.MSCs modified with ACE2 restore endothelial function following LPS challenge by inhibiting the activation of RAS.Featured Article: Electroporation-mediated gene delivery of surfactant protein B (SP-B) restores expression and improves survival in mouse model of SP-B deficiency.β1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury.
P2860
Q26749366-C02606CF-7630-4784-96DF-DDE42896ADAFQ34684913-045A1A73-19CE-4FF0-BAAB-FED656C8459CQ34725627-F5EA3FC7-8C90-425B-927F-29E04F70D574Q35075538-42EB1B25-7669-4675-BAF1-A1BC589227D6Q35140962-64F19D41-7C8E-4538-A195-EAB22E6F3309Q35745720-526E5623-66FE-4426-9779-4D6C5C3A2D50Q35954811-FCF01F90-E993-4603-8726-A696E0D4A6CEQ36601477-203F566A-AD20-4076-9706-7CF8F682BE1CQ37395927-F0EDEE2D-E32D-405F-A77E-9AA9E71C7F96Q38174339-58E53FE8-7F16-4865-83A3-3AF90EB8C6B1Q38202165-2564306D-88A6-40E3-8F2E-27DADC5A3587Q40317649-B3FC4E3A-2197-457C-A518-67346C5DE35AQ43833798-1E6B3BD0-B955-4D72-A8A6-54F916439F94Q45868535-CF4CD686-A96D-4622-BCAF-A543EE7331AFQ45883480-D44192C8-78F0-4B37-897C-86CA6D03EC54
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene therapy for ALI/ARDS.
@en
Gene therapy for ALI/ARDS.
@nl
type
label
Gene therapy for ALI/ARDS.
@en
Gene therapy for ALI/ARDS.
@nl
prefLabel
Gene therapy for ALI/ARDS.
@en
Gene therapy for ALI/ARDS.
@nl
P2860
P1476
Gene therapy for ALI/ARDS.
@en
P2093
P2860
P304
P356
10.1016/J.CCC.2011.04.002
P577
2011-07-01T00:00:00Z